Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$404,040
+$39,311 QoQ
Shares Held
1,443
+5.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#629
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $13,571,646 across 27 Diagnostics & Research names. LH ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
9,924 | $4,975,496 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
9,367 | $4,960,669 | |
| 3 | DHR |
Danaher Corp /De/
|
5,136 | $978,305 | |
| 4 | A |
Agilent Technologies, Inc.
|
4,276 | $567,981 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
932 | $490,642 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
1,443 | $404,040 | |
| 7 | ILMN |
Illumina, Inc.
|
1,331 | $234,029 | |
| 8 | WAT |
Waters Corp /De/
|
533 | $199,896 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $404,040 | 1,443 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $364,729 | 1,367 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,935 | 211 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $44,207 | 154 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,401 | 112 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $29,092 | 125 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $11,924 | 52 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $8,715 | 39 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,733 | 38 | Shares | Sole | 2024-08-02 | |
| No filing history on record for this holder in this stock. | ||||||